Organigram Global Inc. - Common Shares (OGI)
1.1600
-0.0000 (-0.00%)
NASDAQ · Last Trade: Apr 26th, 4:07 PM EDT
Via Benzinga · April 23, 2025
Pre-rolls dominate cannabis sales on both sides of the border—but California and Canada are playing very different games to win.
Via Benzinga · April 22, 2025
Via Benzinga · April 9, 2025
This week in cannabis: major mergers, innovative launches, key regulatory updates & leadership changes drive industry transformation.
Via Benzinga · April 4, 2025
Cannabis news this week: Gaetz sparks cannabis stock rally, Homeland Security reaffirms seizures, key policy moves and major earnings shake the industry.
Via Benzinga · March 28, 2025

British American Tobacco finalizes a C$124.6M investment in Organigram, reinforcing big tobacco's stake in cannabis.
Via Benzinga · March 5, 2025

OGI earnings call for the period ending December 31, 2024.
Via The Motley Fool · February 11, 2025

Organigram's Q1 FY25 sales hit C$66.8M. Net revenue rose 17%, and adjusted EBITDA improved to C$1.4M. Cash position set to reach C$113M.
Via Benzinga · February 11, 2025

DEA judge orders agency to respond to allegations of opposing marijuana rescheduling and improper communication with opponents. Cannabis stocks declined in 2024 due to concerns about DEA review.
Via Benzinga · January 8, 2025

Via Benzinga · January 1, 2025

OGI earnings call for the period ending September 30, 2024.
Via The Motley Fool · December 18, 2024

Organigram's Q4 sales hit $31.22 million, boosted by recreational and international growth, with adjusted gross margin improving to 37% of net revenue.
Via Benzinga · December 18, 2024

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has announced the acquisition of 100% of Motif Labs Ltd. for CA$90 million ($64 million), comprising of CA$50 million in cash and CA$40 million in Organigram common shares, based on a 30-day trading VWAP of $2.321 on the TSX. An additional CA$10 million contingent consideration is payable in shares, conditional on achieving a share price above $3.2203 within 12 months. The deal is financed through Organigram's cash reserves.
Via Benzinga · December 6, 2024

Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.
Via Benzinga · December 5, 2024